Iomeron (Iomeprol)

Iomeprol is a non‑ionic, low‑osmolar iodine‑containing compound. When injected intravenously or intra‑arterially, the iodine atoms absorb X‑ray photons, raising the attenuation of the blood pool and surrounding structures. This creates a temporary contrast between vascular spaces and adjacent tissues, allowing detailed imaging of anatomical features.

The specific dose of Iomeron is determined by the prescribing physician based on the type of imaging study, patient weight, renal function, and clinical protocol. Dosing is individualized and administered by qualified healthcare professionals under controlled conditions.

Iomeron can cross the placenta and is excreted in breast milk. Use during pregnancy or lactation is only considered when the diagnostic benefit outweighs potential risks. The decision should be made by the treating physician in consultation with the patient, taking into account the lack of definitive safety data.

To place an order, submit an enquiry on the Iomeron product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Iomeron (iomeprol) is a low‑osmolar, non‑ionic iodinated contrast medium, offering a favorable safety profile compared with high‑osmolar agents that are associated with higher rates of adverse reactions. Compared with other low‑osmolar agents, its iodine concentration provides comparable image quality, while its formulation is designed for both intra‑arterial and intravenous use.

Iomeron should be stored at 2‑8 °C in a refrigerator, protected from light, and must not be frozen or shaken. Keep the vials in their original packaging until use, and allow the solution to reach room temperature before administration if required by the clinical protocol.

Iomeron is supplied as a sterile solution for injection and is administered by a qualified healthcare professional either intravenously or intra‑arterially, depending on the imaging procedure. The injection is typically performed using a power injector or manual bolus, following the dosing instructions set by the radiologist or physician.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to acute kidney injury, and rare cases of cardiovascular collapse or arrhythmias. Patients with known iodine allergy, impaired renal function, or uncontrolled thyroid disease should be closely monitored, and emergency measures must be readily available.

Iomeron is contraindicated in patients with a documented hypersensitivity to iodinated contrast media, those with uncontrolled hyperthyroidism, and individuals with severe renal impairment where alternative imaging methods are feasible. Caution is also advised for patients on metformin or other nephrotoxic drugs, and the decision to use Iomeron should be made by the treating physician after evaluating risks and benefits.